FAQs

Shares in Quest Diagnostics trade on the New York Stock Exchange under the symbol "DGX."

Fixed Income bonds trade over the counter.

Options on DGX shares are traded on the Chicago Board Options Exchange.

Our transfer agent is Computershare. They can be reached at:

Computershare
P.O. Box 43078
Providence, RI 02940-3078
Telephone inquiries: 800-622-6757 (US, Canada)
781-575-4735 (all other locations)

Overnight correspondence should be sent to:
Computershare
150 Royall St.,
Suite 101
Canton, MA 02021

Shareholder website

Shareholder online inquiries

https://www-us.computershare.com/investor/Contact

Book-entry form of registered ownership allows you to own shares without having paper stock certificates in your possession. You are the record owner and enjoy the same shareholder benefits as you would with certificated shares. If you have book-entry shares, you will receive a statement of your holdings on a yearly basis. You may, of course, request an additional statement at any time by contacting Computershare at 800-622-6757 (US, Canada) or 781-575-4735 (all other locations).

Quest Diagnostics' dividend rate will be $0.66 per share quarterly, beginning on April 20, 2022, which equates to an annual dividend of $2.64 per share.

The Company’s Board of Directors on November 14, 2022, declared a quarterly cash dividend of $0.66 per share, payable on February 1, 2023, to shareholders of record of Quest Diagnostics common stock on January 18, 2023.

Quest Diagnostics executed two-for-one stock splits on May 31, 2001 and on June 20, 2005.

Quest Diagnostics has credit rating relationships with Standard & Poor's, Moody's Investors Service and Fitch Ratings. Standard & Poor's rating is BBB+ with a stable outlook. Our Moody's current credit rating is Baa2 with a stable outlook. Our current credit rating with Fitch is BBB with a stable outlook.

Quest Diagnostics will release financial results for the third quarter ended on September 30, 2022 on October 20, 2022

Contact Investor Relations